Billionaire Stanley Druckenmiller’s New AI Warning and Top 10 Stock Picks

Billionaire Stanley Druckenmiller’s latest stock portfolio is out, but it’s his explosive new prediction about artificial intelligence that is sending shockwaves through Wall Street.

Druckenmiller Says He’s “Not Playing” in the Stock Market

In a recent interview with Morgan Stanley’s Iliana Bouzali, the legendary investor revealed that he had become unusually cautious about the stock market. After nearly 50 years of investing, Druckenmiller said he could barely remember a time when he had so little clarity about where markets were heading over the next 12 months.

“I’m not playing,” he said, explaining that his firm had largely stepped back from making major directional bets.

Druckenmiller said his net equity exposure was roughly flat, with both long and short positions. “We’re trying to not lose money as opposed to make money,” he said. We also covered his new healthcare picks.

His Big AI Prediction: Selling Tasks Instead of Tokens

Druckenmiller believes the next major AI investment opportunity may shift away from infrastructure, including chips and data centers, toward companies that use AI to perform actual business tasks.

He said that beaten-down AI infrastructure stocks could offer tactical opportunities but questioned whether the sector would deliver the same extraordinary investment gains as in previous years.

His bigger prediction concerns leading AI laboratories. Instead of primarily selling access to their models through tokens, companies developing the world’s most powerful AI systems could begin selling completed services directly to customers.

That means businesses could pay AI providers to complete software development, cybersecurity investigations, and other complex tasks rather than purchasing model access and building their own solutions.

Why Cybersecurity Stocks Could Face a Serious Threat

Druckenmiller specifically singled out cybersecurity as an industry potentially vulnerable to this shift.

“Who’s going to compete with these guys in cybersecurity?” he asked.

He said that leading AI laboratories could deploy swarms of intelligent agents capable of defending businesses against increasingly sophisticated cyberattacks.

Such a development could threaten established cybersecurity companies if AI providers begin competing directly for their customers. However, Druckenmiller did not identify individual cybersecurity stocks to sell.

Methodology

For this article, we reviewed Stanley Druckenmiller’s Duquesne Family Office’s third-quarter 2026 13F holdings, as reported to the Securities and Exchange Commission. We selected the firm’s 10 largest non-option holdings based on their reported market values as of September 30, 2026, and ranked them in ascending order of stake value, from the smallest at number 10 to the largest at number one. The list includes both individual stocks and exchange-traded funds, while excluding separately reported call and put options. We also examined changes in the number of shares held during the quarter to determine whether Duquesne increased or reduced each position. His earlier picks are in our list of the best non-AI stocks he owns.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 612% since May 2014, beating its benchmark by 375 percentage points (see more details here).

You can see the top 5 stocks in this list in our video by clicking the image below:

#10 Revolution Medicines, Inc. (NASDAQ:RVMD)

Duquesne Family Office Stake: $89.55 Million

Revolution Medicines develops cancer drugs, and its first approved one, RASONQUE, treats pancreatic cancer. More than 5,000 patients received it in the first five weeks, and health plans covering over 90% of US pancreatic cancer lives have reimbursed claims. Most patients had other treatments first, so earlier use can add sales.

The stock trades at about 57 times forward sales, while the median healthcare stock trades at about 3.5 times. Early sales included one-time boosts from patients moving over from the Expanded Access Program, which will fade. Costs and net loss rose from a year earlier. Revolution Medicines has little room for a slow launch.

Stanley Druckenmiller’s Duquesne Family Office increased its stake in Revolution Medicines by approximately 10% during the third quarter of 2026. According to its latest 13F filing, the firm held 436,287 shares worth approximately $89.55 million as of September 30, accounting for 2.00% of its reported portfolio. Click to read our earlier take on this biotech pick.

#9 Insmed Incorporated (NASDAQ:INSM)

Duquesne Family Office Stake: $124.72 Million

Duquesne Family Office reduced its Insmed shareholding by approximately 23% during the third quarter of 2026. At the end of September, the firm owned 1,092,650 common shares worth approximately $124.72 million, representing 2.79% of its reported portfolio. This excludes a separately reported call-option position in Insmed.

Insmed Incorporated makes lung disease drugs, and its pill BRINSUPRI is the only approved medicine for non-cystic fibrosis bronchiectasis. Management raised its 2026 BRINSUPRI sales guidance twice. An FDA decision in January 2027 could widen who can use its older drug ARIKAYCE, and the pipeline drug TPIP is in Phase 3 trials for high blood pressure in the lungs.

BRINSUPRI made up 76.3% of third quarter sales, so the company depends on one drug. Boehringer Ingelheim has a rival pill that works the same way in Phase 3, and AstraZeneca collects royalties that rise as sales grow. Research costs for TPIP keep climbing. Insmed Incorporated needs BRINSUPRI to keep growing fast to cover them. See our take on this healthcare stock.

#8 iShares MSCI Brazil ETF (NYSEARCA:EWZ)

Duquesne Family Office Stake: $125.81 Million

The iShares MSCI Brazil ETF is an exchange-traded fund designed to track the performance of large- and mid-capitalization Brazilian equities. It provides exposure to major Brazilian companies across sectors such as financial services, energy, materials, and consumer businesses.

Duquesne Family Office decreased its position in the iShares MSCI Brazil ETF by approximately 2% during the third quarter. The firm reported ownership of 3,377,570 ETF shares worth approximately $125.81 million at the end of September 2026. The holding represented 2.81% of its reported portfolio.

#7 Sea Limited (NYSE:SE)

Duquesne Family Office Stake: $155.07 Million

Stanley Druckenmiller’s Duquesne Family Office increased its stake in Sea Limited by approximately 45% during the third quarter of 2026. As of September 30, the firm owned 1,592,765 shares valued at approximately $155.07 million. The investment accounted for 3.47% of its reported portfolio.

Sea Limited runs Shopee, an online marketplace in Southeast Asia, Monee, its lending business, and Garena, a gaming company. In the third quarter, revenue grew 43% from the same quarter a year earlier and adjusted EBITDA grew 29%. Monee revenue grew 64% in that quarter. The company also plans to sell its internal AI cloud platform to other businesses through Sea Cloud, and management says this needs little spending on data centers.

Bears say Sea Limited’s growth could slow from here. Garena bookings grew 6% in the third quarter from a year earlier, down from 15% in the second quarter, and Shopee’s order value growth also slowed. Shopee’s profit margin stayed flat from the second quarter even though its take rate rose, and bears think heavy spending on faster delivery and marketing could keep margins low. Sea Cloud has not signed any customers yet and would compete with Amazon, Google and Alibaba. Read our take on Howard Marks’ bet on the stock.

#6 Unity Software Inc. (NYSE:U) 

Duquesne Family Office Stake: $161.94 Million

Unity Software Inc. makes the software many game developers use to build their games, and it also runs an ad network. A game maker pays Unity to show ads for its game inside other games, and Unity’s software picks which ad to show to which player. This helps the game maker find new players. Bulls think this ad business can keep growing because Unity’s Vector model is getting better at picking ads that work. In the third quarter, revenue from its Strategic Grow ad business grew 90% from a year earlier, and management says most of that growth came from existing advertisers spending more after seeing better returns. The ad market is also growing at double digits, so Unity Software Inc. may not need to take share from rivals.

Duquesne Family Office aggressively expanded its Unity Software investment during the third quarter of 2026, increasing its shareholding by approximately 436%. At the end of September, the firm owned 3,956,385 Unity shares valued at approximately $161.94 million, representing 3.62% of its reported portfolio. Unity recorded the largest percentage increase in share count among Duquesne’s ten largest non-option holdings. Find out if this is a good stock to buy now.

#5 YPF Sociedad Anónima (NYSE:YPF)

Duquesne Family Office Stake: $177.56 Million

YPF Sociedad Anónima is an Argentine oil and gas company. It produces oil and gas, mostly shale oil from the Vaca Muerta field, refines oil and sells fuel. The Argentine government owns about 51% of it.

YPF Sociedad Anónima has a growing shale oil business. Bulls think it can keep growing its output from Vaca Muerta, where shale oil production in the third quarter grew 32% from a year earlier. The VMOS pipeline, in which YPF holds a 30% stake, should help it export more oil once oil starts flowing in early 2027. The stock also trades at about 4 times forward earnings, while the median energy stock trades at about 11 times.

Bears say the government’s 51% stake means decisions may not always favor shareholders. Higher oil prices helped recent results, and lower prices could cut profits. The company has heavy spending ahead, and the Argentina LNG project alone needs large investments through 2031, which could leave little cash for investors. YPF Sociedad Anónima has to manage all of this while oil prices move.

Duquesne Family Office increased its YPF stake by approximately 13% during the third quarter of 2026. The firm held 3,541,897 American depositary shares worth approximately $177.56 million as of September 30. The investment represented 3.97% of Duquesne’s reported portfolio. Howard Marks’ Oaktree also owns YPF, so see his non-AI picks.

#4 Fox Corporation (NASDAQ:FOXA)

Duquesne Family Office Stake: $190.84 Million

Fox Corporation owns Fox News, the Fox broadcast network and Fox Sports, which carries big events like NFL games and the World Cup. Bulls think its two main businesses, sports and news, can keep growing. In its recently reported quarterly results, revenue grew 22% from the same quarter a year earlier, and advertising revenue grew 47%, helped by record World Cup viewership. Fox News ratings fell 28% in that quarter from a year earlier, and bulls think that dip comes from the midterm elections and will fade, as it has before.

Bears say the World Cup boost may not repeat. Fox’s rights are up for renewal, and Amazon, Netflix, YouTube and Disney are expected to bid, which could push the price much higher. Cable subscribers are still leaving, and the results show no sign that this has slowed. A court also reinstated a jury verdict against the NFL over its out-of-market game sales, and Fox has said changes to those rules could be an existential threat to it. Fox Corporation is not part of the case.

Stanley Druckenmiller’s Duquesne Family Office increased its principal reported Fox Corporation position by approximately 38% during the third quarter of 2026. As of September 30, the firm held 3,046,050 Class A shares worth approximately $190.84 million. This position accounted for 4.27% of the reported portfolio. Read the bull case on the company and its Tubi streaming business.

#3 Amazon.com, Inc. (NASDAQ:AMZN)

Duquesne Family Office Stake: $192.49 Million

Druckenmiller has sounded cautious on AI stocks, but he added to Amazon in the third quarter.

Duquesne Family Office increased its Amazon common-stock position by approximately 43% during the third quarter of 2026. The firm held 772,600 shares worth approximately $192.49 million as of September 30, representing 4.31% of its reported portfolio.

In addition to its common-stock holding, Duquesne separately reported Amazon call options covering 459,300 underlying shares, with a reported value of approximately $114.44 million.

Amazon.com, Inc. has two long growth runways in cloud computing and online shopping. Management says about 85% of global IT spending is still on company-owned servers and could move to the cloud over the next 10 to 20 years. In its recently reported quarterly results, AWS revenue grew 39.3% from the same quarter a year earlier, its fastest pace in almost five years. Customer commitments for Amazon’s own AI chips are also up more than 20 times from a year earlier, and Amazon plans to sell those chips outside AWS in late 2027. About 80% of retail sales still happen in physical stores, so online shopping has room to take more. See whether it is a good AI stock for long-term investors.

#2 Seagate Technology Holdings plc (NASDAQ:STX)

Duquesne Family Office Stake: $315.25 Million

Bulls say Seagate Technology Holdings plc (NASDAQ:STX) is attractively valued. It trades at a forward P/E of 12.9, below the sector median of 19.0, and its forward PEG ratio is 0.16 against a sector median of 1.04. Forward revenue growth is estimated at about 46% as its new HAMR hard drives ramp up.

But bears say there is a reason the stock fell more than 25% since October 6. Investors have been selling AI and chip stocks over doubts that AI companies can earn back their huge data center spending. Seagate sells storage drives to those data centers, and hard drive demand runs in cycles. If AI spending slows, earnings could fall and the low P/E would not be a bargain. Seagate Technology Holdings plc (NASDAQ:STX) needs that spending to continue.

Duquesne Family Office substantially increased its investment in Seagate during the third quarter of 2026, expanding its common-stock position by approximately 180%. At the end of September, the firm owned 341,790 shares worth approximately $315.25 million, representing 7.05% of its reported portfolio.

Duquesne also established a separate Seagate call-option position covering 98,000 underlying shares, with a reported value of approximately $90.39 million. Click to read whether the stock is a buy after its recent declines.

#1 Natera, Inc. (NASDAQ:NTRA)

Duquesne Family Office Stake: $1.31 Billion

Natera, Inc. makes blood tests that detect cancer recurrence, screen pregnancies and monitor organ transplants. Bulls think its cancer test, Signatera, can keep growing for years. In the third quarter, the number of cancer recurrence tests grew 56% from a year earlier, Medicare added coverage for liver cancer, and drug companies are using the test in more clinical trials. Natera is also preparing a launch in Japan and running a large study on early cancer detection. Management has set a goal to double revenue in three years.

Bears say the stock’s drop after the quarter shows how much was already expected. Natera reported a bigger loss per share than analysts expected in the third quarter, and its CEO of almost 8 years stepped down on the same day. The stock trades at about 13.6 times forward sales, while the sector median is about 3.5. New rivals are entering the cancer test market, and Natera is spending heavily on early cancer detection, which earns no revenue yet. Natera, Inc. also depends on Medicare and insurers to keep approving its tests.

Natera remained Stanley Druckenmiller’s largest disclosed investment at the end of the third quarter of 2026. Although Duquesne Family Office reduced its shareholding by approximately 1% during the quarter, the firm still owned 3,160,666 Natera shares worth approximately $1.31 billion as of September 30. Read why Druckenmiller likes this cancer stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Follow Insider Monkey on Google News.